Aurora Cannabis sees growth with high-margin medical cannabis, debt cuts, and EBITDA gains. Click here to read an analysis of ACB stock now.

This was the stock's fourth consecutive day of gains.

Aurora Cannabis Q4 sales rose 34% to $63.07 million, led by medical cannabis and plant propagation, despite missing earnings estimates.

Read about Aurora Cannabis Inc (ACB:XNAS) stock and today's latest news and financial updates. ACB - Aurora Cannabis Inc News | Morningstar Morningstar brands and products ...

Aurora Cannabis shares tumbled Wednesday as the Canadian cannabis operator said it expects “temporary declines” in its ...

It was a rough week for Aurora Cannabis (TSX:ACB)(NASDAQ:ACB) whose shares fell last week through no fault of its own. The ...

Empowering Canadian innovation—discover, invest, and grow with homegrown tech leaders shaping the future. The 2025 Cantech ...

Proprietary Genetics to be the Highest Potency Medical Cannabis Products Available on the Market NASDAQ | TSX: ACB EDMONTON, AB, June 24, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ...

Aurora Cannabis (ACB) delivered earnings and revenue surprises of -36.36% and 1.65%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Aurora Cannabis Inc. advanced stock charts by Barron's. View ACB historical stock data and compare to other stocks, and exchanges.

Shares of Aurora Cannabis Inc. ACB rallied 3.95% to $4.47 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.94% to ...